Summitry LLC Has $43.48 Million Holdings in Rentokil Initial PLC $RTO

Summitry LLC boosted its position in Rentokil Initial PLC (NYSE:RTO) by 1.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,475,957 shares of the company’s stock after purchasing an additional 25,170 shares during the period. Rentokil Initial makes up approximately 1.8% of Summitry LLC’s holdings, making the stock its 21st biggest position. Summitry LLC’s holdings in Rentokil Initial were worth $43,482,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Envestnet Asset Management Inc. lifted its holdings in Rentokil Initial by 105.8% in the third quarter. Envestnet Asset Management Inc. now owns 1,553,740 shares of the company’s stock valued at $39,232,000 after buying an additional 798,660 shares during the period. Clark Estates Inc. NY acquired a new position in Rentokil Initial in the third quarter valued at $8,332,000. Nichols & Pratt Advisers LLP MA lifted its holdings in Rentokil Initial by 5.9% in the third quarter. Nichols & Pratt Advisers LLP MA now owns 871,415 shares of the company’s stock valued at $22,003,000 after buying an additional 48,184 shares during the period. Advisor OS LLC acquired a new position in Rentokil Initial in the third quarter valued at $1,014,000. Finally, Bleakley Financial Group LLC acquired a new position in Rentokil Initial in the third quarter valued at $1,132,000. Institutional investors and hedge funds own 9.91% of the company’s stock.

Wall Street Analyst Weigh In

RTO has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Rentokil Initial from a “buy” rating to a “hold” rating in a report on Tuesday, February 24th. Zacks Research upgraded shares of Rentokil Initial from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. UBS Group upgraded shares of Rentokil Initial from a “neutral” rating to a “buy” rating in a report on Thursday, March 12th. Wall Street Zen lowered shares of Rentokil Initial from a “buy” rating to a “hold” rating in a report on Sunday, April 5th. Finally, Oppenheimer boosted their target price on shares of Rentokil Initial from $30.00 to $35.00 and gave the company an “outperform” rating in a report on Tuesday, March 10th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Rentokil Initial currently has a consensus rating of “Moderate Buy” and a consensus target price of $34.50.

Rentokil Initial Stock Performance

Shares of NYSE RTO opened at $31.38 on Tuesday. The firm’s 50-day moving average price is $32.64 and its 200-day moving average price is $30.91. Rentokil Initial PLC has a 1-year low of $22.72 and a 1-year high of $34.67. The company has a current ratio of 1.16, a quick ratio of 1.07 and a debt-to-equity ratio of 0.76.

Rentokil Initial Dividend Announcement

The business also recently disclosed a dividend, which was paid on Tuesday, May 19th. Stockholders of record on Friday, April 10th were issued a dividend of $0.412 per share. The ex-dividend date was Friday, April 10th. This represents a dividend yield of 245.0%.

Rentokil Initial Profile

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.